Endocyte, Inc. to Present at the 18th Annual BioCentury NewsMakers Conference

WEST LAFAYETTE, Ind., Oct. 14, 2011 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy, today announced that Mike Sherman, chief financial officer of Endocyte, will present at the upcoming 18th Annual Newsmakers in the Biotech Industry Conference on Friday, Oct. 21, 2011 at 2:30 p.m. EDT. The conference will be held at the Millennium Broadway Hotel in New York.

MORE ON THIS TOPIC